Don't miss SGLT Tools - PowerPoint slide library for SGLT2 inhibitors

Potassium in hemodialytic Death Study

In order to vote and see your remaining funds, please log in here
Current total funding for this study: $103,000

Author:

Graham Abra
Nephrologist

Study Acronym:

PhD

Observational data have shown that both lower and higher serum potassium are associated with mortality in hemodialysis patients. The standard response to hyperkalemia is to lower the dialysate potassium. Unfortunately, low dialysate potassium is associated with increased mortality.

In my DreamRCT hyperkalemic dialysis patients would be randomized to one of the new potassium binders (ZS-9 and patiromer) or placebo.

The primary outcome is sudden cardiac death.

Secondary outcomes would include hospitalization for hyperkalemia, hospitalization for arrhythmia, new arrhythmia diagnosis, and questionnaire defined potassium intake.

Comments (0)

There are no comments posted here yet

Leave your comments

  1. Posting comment as a guest. Sign up or login to your account.
Attachments (0 / 3)
Share Your Location
ukidneyisup